IGES Experten vor Ort
07.11.23
Fabian Berkemeier | IGES Gruppe
Moderation
Fireside Chat: The new, centralized assessment process relevant for reimbursement of pharmaceuticals in the EU
Speaker: Kevin Rieger (BeiGene)
From 2025, a centralized clinical evaluation of new pharmaceuticals will take place in the European Union (EU). The new procedure is a milestone, because until now reimbursement has been exclusively at the level of the individual member states of the EU. Although initial reimbursement and pricing will remain in the hands of the individual EU countries, the future centralized clinical evaluation will provide a uniform basis for reimbursement decisions in the individual EU countries. The new procedure is therefore one of the most far-reaching innovations in EU pharmaceutical legislation for decades. This talk will focus on how companies with innovative products can best prepare for the new procedure. What do I have to do today to ensure that my product finds its way to patients in the EU from 2025? How do I have to set up my clinical studies now so that they meet the new requirements? What points are still open?
Veranstaltung: BIO-EUROPE 2023
Kongress
Veranstaltungssprache: Englisch
Zeit: 11.00 - 11.30 Uhr
